Defining the relationship between COPD and CVD: what are the implications for clinical practice?
Top Cited Papers
Open Access
- 1 January 2018
- journal article
- research article
- Published by SAGE Publications in Therapeutic Advances in Respiratory Disease
- Vol. 12
Abstract
Cardiovascular diseases (CVDs) are arguably the most important comorbidities in chronic obstructive pulmonary disease (COPD). CVDs are common in people with COPD, and their presence is associated with increased risk for hospitalization, longer length of stay and all-cause and CVD-related mortality. The economic burden associated with CVD in this population is considerable and the cumulative cost of treating comorbidities may even exceed that of treating COPD itself. Our understanding of the biological mechanisms that link COPD and various forms of CVD has improved significantly over the past decade. But despite broad acceptance of the prognostic significance of CVDs in COPD, there remains widespread under-recognition and undertreatment of comorbid CVD in this population. The reasons for this are unclear; however institutional barriers and a lack of evidence-based guidelines for the management of CVD in people with COPD may be contributory factors. In this review, we summarize current knowledge relating to the prevalence and incidence of CVD in people with COPD and the mechanisms that underlie their coexistence. We discuss the implications for clinical practice and highlight opportunities for improved prevention and treatment of CVD in people with COPD. While we advocate more active assessment for signs of cardiovascular conditions across all age groups and all stages of COPD severity, we suggest targeting those aged under 65 years. Evidence indicates that the increased risks for CVD are particularly pronounced in COPD patients in mid-to-late-middle-age and thus it is in this age group that the benefits of early intervention may prove to be the most effective.Keywords
Funding Information
- British Lung Foundation (RG14-15)
This publication has 100 references indexed in Scilit:
- Comorbidities and Burden of COPD: A Population Based Case-Control StudyPLOS ONE, 2013
- Comorbidities in current COPD guidelines2013
- Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional studyThe Lancet, 2012
- Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Airflow Obstruction, Lung Function, and Risk of Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) StudyEuropean Journal of Heart Failure, 2012
- Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEuropean Respiratory Journal, 2008
- Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular riskThorax, 2008
- Role of Lung Maintenance Program in the Heterogeneity of Lung Destruction in EmphysemaProceedings of the American Thoracic Society, 2006
- C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary diseaseThorax, 2006
- Inflammation in atherosclerosisNature, 2002